What’s the difference between the Wegovy pill and Rybelsus?
Both are made by Novo Nordisk, both contain semaglutide, and both are tablets taken once a day. The drug and the form are identical.
The two differences that matter are the dose and the licence.
The Wegovy pill is dosed up to 25 mg a day and is licensed for weight management in people living with obesity.
Rybelsus is dosed up to 14 mg a day and is licensed only to lower blood sugar in type 2 diabetes.
| Feature |
Wegovy pill |
Rybelsus |
| Drug |
Semaglutide |
Semaglutide |
| Form |
Tablet, once a day |
Tablet, once a day |
| Licensed in the UK for |
Weight management (obesity) |
Type 2 diabetes only |
| Highest dose |
25 mg a day |
14 mg a day |
| Dose steps |
1.5 mg, rising to 4 mg, 9 mg, then 25 mg |
3 mg, rising to 7 mg, then 14 mg |
| Average weight loss in trials |
13.6% over 64 weeks (OASIS 4)1 |
Around 4 kg over 26 weeks in type 2 diabetes (PIONEER 4)2 |
| How to take it |
Empty stomach, small sip of water, 30-minute wait before food or drink |
Empty stomach, small sip of water, 30-minute wait before food or drink |
| Most common side effects |
Nausea, diarrhoea, vomiting, constipation |
Nausea, diarrhoea, vomiting, constipation |
| UK status |
MHRA-approved June 2026; rolling out privately |
Available on prescription for type 2 diabetes since 2020 |
For anyone searching for a semaglutide tablet to lose weight, the Wegovy pill is the only oral GLP-1 approved in the UK for weight loss.
Are the Wegovy pill and Rybelsus the same drug?
They contain the same drug, semaglutide, but they aren’t the same medicine.
The Wegovy pill isn’t simply Rybelsus rebranded for weight loss. It’s a separate product with a higher dose and a different licence, developed and tested specifically for weight management.
Semaglutide is also sold as Ozempic, a weekly injection for type 2 diabetes, and as the Wegovy injection for weight loss. So the same drug appears under several brand names, at different doses, for different uses.
So the drug is the same, but the dose and the licence are the primary differences between the Wegovy pill and Rybelsus.
How the Wegovy pill and Rybelsus work
Both tablets work in the same way because they contain the same drug.
Semaglutide mimics GLP-1, a hormone our gut releases after eating. It slows the rate at which our stomach empties and communicates with the appetite centre in the brain, which reduces hunger and food noise.
The reason the doses look so high compared with the injection comes down to absorption.
Semaglutide is a peptide, and peptides are normally broken down in the stomach before they can be absorbed. To get around this, both tablets pair semaglutide with an ingredient called SNAC, which helps a small amount of the drug pass through the stomach lining.
Even with SNAC, only around 1% of each tablet reaches the bloodstream. That’s why an oral dose has to be much larger than an injected one to have a similar effect.
It’s also the reason the dose differs so much between the two tablets. The Wegovy pill goes up to 25 mg a day, enough to produce the 13.6% average weight loss seen in trials, while Rybelsus stops at 14 mg, a dose set for blood sugar control rather than weight loss.
Do you lose more weight on the Wegovy pill or Rybelsus?
The Wegovy pill produces substantially more weight loss than Rybelsus.
In the OASIS 4 trial, adults with overweight or obesity who took the 25 mg Wegovy pill lost an average of 13.6% of their body weight over 64 weeks, compared with 2.2% on a placebo.1
Rybelsus has only been studied at its licensed doses in people living with type 2 diabetes, where weight loss is a secondary benefit rather than the goal.
In the PIONEER 4 trial, Rybelsus 14 mg reduced body weight by about 4 kg over 26 weeks, roughly 4 to 5% of body weight for many of the people taking it.2
The main reason for the difference in weight loss is the dose. The Wegovy pill’s highest dose is 25 mg, and Rybelsus’s highest dose is 14 mg; semaglutide’s effects on appetite, cravings, and blood sugar increase with the dose.
The trial populations differ too. Rybelsus was studied in people living with type 2 diabetes, and weight loss on GLP-1 medications tends to be smaller in people with diabetes than in those without.
The Wegovy injection produces more weight loss again, an average of 20.7% at its highest dose of 7.2 mg, because an injection avoids the absorption problem entirely.5 Our Wegovy vs Rybelsus guide covers the injection comparison.
Can you take Rybelsus for weight loss?
Rybelsus isn’t licensed for weight loss in the UK, only for type 2 diabetes.
A prescriber can still choose to prescribe it off-label, which means using a medication outside its licensed purpose, but they have to justify that decision and explain the risks.
The practical issue is the dose. At 14 mg, Rybelsus produces only about 4-5% weight loss (in individuals living with type 2 diabetes; in non-diabetic populations, this might be higher), which is lower than the 13.6% average weight loss with the Wegovy pill.
Now that the Wegovy pill is available in the UK, the licensed oral option for weight loss is the higher-dose 25 mg tablet, rather than an off-label prescription of Rybelsus.
How to take the Wegovy pill and Rybelsus
Both tablets follow the same strict dosing routine because they rely on SNAC for absorption.
You take the tablet first thing in the morning on an empty stomach, with no more than a small sip of plain water.3,4
After taking it, you wait at least 30 minutes before eating, drinking anything else, or taking other tablets.
Taking it with food, with too much water, or too soon before eating means much less of the dose is absorbed, so it won’t work as well.
The dose is increased slowly to reduce side effects. The Wegovy pill starts at 1.5 mg and rises through 4 mg and 9 mg to 25 mg, while Rybelsus starts at 3 mg and rises through 7 mg to 14 mg, with about a month at each step.
Side effects and safety
Because both tablets contain the same drug, their side effects are very similar.
The most common are gut-related, such as nausea, diarrhoea, vomiting, and constipation. They’re usually most noticeable in the first few weeks as the dose goes up, then they tend to settle.
In the OASIS 4 trial of the Wegovy pill, nausea affected around 47% of people, and about 74% had at least one gut-related side effect. Around 7% stopped the medication because of side effects.1
Rybelsus shows a similar pattern of gut-related side effects across its trials, in line with it being the same drug.3
People vary in how well they tolerate these medications, so some manage one dose more comfortably than another.
Both share the rarer but more serious risks listed for the GLP-1 class, including pancreatitis and gallbladder problems, so any severe or persistent stomach pain should be checked by a doctor.3
Anyone with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2 shouldn’t take semaglutide in any form.
Always tell your prescriber about your full medical history and report any side effects you experience.
How much do the Wegovy pill and Rybelsus cost in the UK?
The Wegovy pill was approved by the MHRA in June 2026 and is rolling out through private providers. It isn’t available on the NHS yet, as that would follow a separate NICE assessment.4
There’s no official UK list price for the pill yet, so each provider sets its own. Private monthly prices are similar to those for the Wegovy injection, at roughly £150 to £250 a month, depending on the dose and provider.
Rybelsus is prescribed on the NHS for type 2 diabetes, where you pay the standard prescription charge, or nothing if you’re exempt.
Privately, Rybelsus typically costs between £170 and £280 a month. Because it isn’t licensed for weight loss, any private prescription for that purpose would be off-label.
Our cost comparison tool has more detail on the cost of GLP-1 weight-loss medications.
If a semaglutide tablet appeals more than an injection, a clinician can tell you whether the Wegovy pill is right for you. Second Nature has worked with the NHS since 2017, combining weight-loss medication with structured habit support to achieve lasting weight loss. Take our 3-minute eligibility quiz, and a clinician will review your answers.
Building habits alongside the medication
Both tablets reduce appetite and quiet food noise, making it easier to build healthier eating habits. Those new habits are what help to improve all-round health and prevent weight regain in the future.
We recommend eating a diet based on whole foods that contains enough protein, fibre, fat, and complex carbohydrates, and limits ultra-processed foods.
Getting enough protein helps protect muscle while you’re losing weight. A useful guide is to aim for a portion of protein about the size of the palm of your hand at each meal.
A balanced plate is roughly half vegetables, a quarter protein, and a quarter complex carbohydrates such as wholegrain bread, brown rice, or potatoes, with a serving of healthy fat alongside.
If you stop semaglutide suddenly without having built the habits to manage hunger naturally, some weight regain is likely, because appetite and food noise return.
Coming off slowly, by gradually reducing the dose while you maintain your healthy habits will give you the best chance of preventing weight regain in the future.
Take home message
The Wegovy pill and Rybelsus are the same drug, semaglutide, in the same form, a daily tablet, but they aren’t the same medicine.
The Wegovy pill is a 25 mg tablet licensed for weight loss, and produced an average weight loss of 13.6% in trials.
Rybelsus is a lower-dose tablet, up to 14 mg, licensed only for type 2 diabetes, where it leads to more modest weight loss of around 4 kg.
If you specifically want a semaglutide tablet for weight loss, the licensed option is the Wegovy pill, not Rybelsus.
Their side effects are very similar because the drug is the same, and both need the same morning fasting routine to improve absorption and effectiveness.
Second Nature combines medication with personalised nutrition guidance from registered dietitians and nutritionists, built around a balanced plate of vegetables, protein, complex carbohydrates, and healthy fats.
The research suggests you’re more likely to avoid weight regain when the medication is paired with that kind of habit support than when it’s prescribed on its own.
Our published research found an average weight loss of 19.1% at 12 months in active subscribers on a GLP-1-supported programme, with 77.7% losing at least 10% of their body weight.6
Second Nature's Mounjaro and Wegovy programmes
Second Nature provides Mounjaro or Wegovy as part of our Mounjaro and Wegovy weight-loss programmes.
Why choose Second Nature over other medication providers, assuming you're eligible?
Because peace of mind matters.
We've had the privilege of working with the NHS for over eight years, helping people across the UK take meaningful steps toward a healthier, happier life.
Our programmes are designed to meet people where they are, whether that means support with weight loss through compassionate one-to-one health coaching, or access to the latest weight-loss medications (like Mounjaro and Wegovy) delivered alongside expert care from a multidisciplinary team of doctors, psychologists, dietitians, and personal trainers.
At the heart of everything we do is a simple belief: real, lasting change comes from building better habits, not relying on quick fixes. We're here to support that change every step of the way.
With over a decade of experience, thousands of lives changed, and a long-standing record of delivering programmes used by the NHS, we believe we're the UK's most trusted weight-loss programme.
We hope to offer you something invaluable: peace of mind, and the support you need to take that first step.
Frequently asked questions
Are the Wegovy pill and Rybelsus the same thing?
No. They contain the same drug, semaglutide, and both are daily tablets, but the Wegovy pill is a higher dose (25 mg) licensed for weight loss, while Rybelsus is a lower dose (up to 14 mg) licensed only for type 2 diabetes.
Is oral Wegovy just Rybelsus?
No. The Wegovy pill is a separate, higher-dose product developed for weight management, not Rybelsus under a different name. Rybelsus was designed and dosed for blood sugar control in type 2 diabetes.
Do you lose more weight on the Wegovy pill or Rybelsus?
The Wegovy pill. It produced an average weight loss of 13.6% in trials, compared with roughly 4 kg (about 4-5%) with Rybelsus 14 mg. The higher 25 mg dose is the main reason.
Can you take Rybelsus for weight loss?
Rybelsus isn’t licensed for weight loss in the UK, only for type 2 diabetes. A prescriber can prescribe it off-label, but its 14 mg dose produces only about 4-5% weight loss, so the Wegovy pill is the licensed oral option for weight loss.
Can you switch from Rybelsus to the Wegovy pill?
This is a decision for your prescriber, and it’s a change of medication rather than a simple dose increase, because the two are licensed for different conditions. Never switch between semaglutide products without medical advice.
Why is the Wegovy pill a higher dose than Rybelsus?
Only about 1% of an oral dose of semaglutide is absorbed, so oral doses have to be high.
The Wegovy pill goes up to 25 mg to produce weight loss, while Rybelsus stops at 14 mg, a dose set for blood sugar control.
Is the Wegovy pill available on the NHS?
Not yet. It was approved by the MHRA in June 2026 and is available privately, but NHS access would follow a separate NICE assessment.
What are the side effects of the Wegovy pill and Rybelsus?
The most common side effects of both are gut-related: nausea, diarrhoea, vomiting, and constipation. They’re usually mild to moderate and settle after the first few weeks. Both also carry rarer risks such as pancreatitis and gallbladder problems.
Which is better for type 2 diabetes, the Wegovy pill or Rybelsus?
Rybelsus is licensed for type 2 diabetes, so it’s the relevant option for blood sugar control. The Wegovy pill is licensed for weight loss rather than diabetes. A prescriber will help you make a decision based on your blood sugar, weight, and other health factors.
